Who are Ipratropium + Levosalbutamol Free Dose Combination's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ipratropium/albuterol, Atrovent + Bricanyl or Atrovent + Ventoline, Duovent HFA.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ipratropium-levosalbutamol-free-dose-combination.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Ipratropium + Levosalbutamol Free Dose Combination — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ipratropium + Levosalbutamol Free Dose Combination (Ipratropium + Levosalbutamol Free Dose Combination) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination bronchodilator (anticholinergic + beta-2 agonist). Area: Respiratory.

phase 3 Combination bronchodilator (anticholinergic + beta-2 agonist) Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Ipratropium + Levosalbutamol Free Dose Combination (Ipratropium + Levosalbutamol Free Dose Combination) — Neutec Ar-Ge San ve Tic A.Ş. This combination uses an anticholinergic bronchodilator (ipratropium) and a short-acting beta-2 agonist (levosalbutamol) to relax airway smooth muscle through complementary pathways.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Ipratropium + Levosalbutamol Free Dose Combination TARGET	Ipratropium + Levosalbutamol Free Dose Combination	Neutec Ar-Ge San ve Tic A.Ş	phase 3	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor
Ipratropium/albuterol	Ipratropium/albuterol	National Jewish Health	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (ipratropium); beta-2 adrenergic receptor (albuterol)
Atrovent + Bricanyl or Atrovent + Ventoline	Atrovent + Bricanyl or Atrovent + Ventoline	University Hospital, Tours	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor
Duovent HFA	Duovent HFA	Centre Hospitalier Universitaire UCLouvain Namur	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination bronchodilator (anticholinergic + beta-2 agonist) class)

Centre Hospitalier Universitaire UCLouvain Namur · 1 drug in this class
National Jewish Health · 1 drug in this class
Neutec Ar-Ge San ve Tic A.Ş · 1 drug in this class
University Hospital, Tours · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ipratropium + Levosalbutamol Free Dose Combination — Competitive Intelligence Brief. https://druglandscape.com/ci/ipratropium-levosalbutamol-free-dose-combination. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab